191 related articles for article (PubMed ID: 15890247)
1. Roles of mismatch repair proteins hMSH2 and hMLH1 in the development of sporadic breast cancer.
Murata H; Khattar NH; Gu L; Li GM
Cancer Lett; 2005 Jun; 223(1):143-50. PubMed ID: 15890247
[TBL] [Abstract][Full Text] [Related]
2. Histopathology and mismatch repair status of 458 consecutive colorectal carcinomas.
Wright CL; Stewart ID
Am J Surg Pathol; 2003 Nov; 27(11):1393-406. PubMed ID: 14576472
[TBL] [Abstract][Full Text] [Related]
3. hMLH1 and hMSH2 expression in human hepatocellular carcinoma.
Wang L; Bani-Hani A; Montoya DP; Roche PC; Thibodeau SN; Burgart LJ; Roberts LR
Int J Oncol; 2001 Sep; 19(3):567-70. PubMed ID: 11494037
[TBL] [Abstract][Full Text] [Related]
4. Significance of mismatch repair protein expression in the chemotherapeutic response of sporadic invasive ductal carcinoma of the breast.
Son BH; Ahn SH; Ko CD; Ka IW; Gong GY; Kim JC
Breast J; 2004; 10(1):20-6. PubMed ID: 14717755
[TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic modification of mismatch repair genes hMSH2 and hMLH1 in sporadic breast cancer with microsatellite instability.
Murata H; Khattar NH; Kang Y; Gu L; Li GM
Oncogene; 2002 Aug; 21(37):5696-703. PubMed ID: 12173039
[TBL] [Abstract][Full Text] [Related]
6. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
[TBL] [Abstract][Full Text] [Related]
7. Loss of expression of DNA repair enzymes MGMT, hMLH1, and hMSH2 during tumor progression in gastric cancer.
Kitajima Y; Miyazaki K; Matsukura S; Tanaka M; Sekiguchi M
Gastric Cancer; 2003; 6(2):86-95. PubMed ID: 12861399
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples.
Wang YC; Lu YP; Tseng RC; Lin RK; Chang JW; Chen JT; Shih CM; Chen CY
J Clin Invest; 2003 Mar; 111(6):887-95. PubMed ID: 12639995
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation.
Scott S; Kimura T; Ichinohasama R; Bergen S; Magliocco A; Reimer C; Kerviche A; Sheridan D; DeCoteau JF
Leuk Res; 2003 Jan; 27(1):23-34. PubMed ID: 12479849
[TBL] [Abstract][Full Text] [Related]
10. Defective mismatch repair and the development of recurrent endometrial carcinoma.
Pijnenborg JM; Dam-de Veen GC; de Haan J; van Engeland M; Groothuis PG
Gynecol Oncol; 2004 Aug; 94(2):550-9. PubMed ID: 15297202
[TBL] [Abstract][Full Text] [Related]
11. [Mismatch repair gene promoter methylation and expression in hydatidiform moles and the malignant transformation].
Zhu CK; Ye DF; Xie X; Cheng XD; Chen HZ; Lu WG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):422-6. PubMed ID: 12974087
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.
Cunningham JM; Christensen ER; Tester DJ; Kim CY; Roche PC; Burgart LJ; Thibodeau SN
Cancer Res; 1998 Aug; 58(15):3455-60. PubMed ID: 9699680
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite instability and hMLH1 and hMSH2 expression analysis in soft tissue sarcomas.
Kawaguchi K; Oda Y; Takahira T; Saito T; Yamamoto H; Kobayashi C; Tamiya S; Oda S; Iwamoto Y; Tsuneyoshi M
Oncol Rep; 2005 Feb; 13(2):241-6. PubMed ID: 15643505
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes.
Thibodeau SN; French AJ; Roche PC; Cunningham JM; Tester DJ; Lindor NM; Moslein G; Baker SM; Liskay RM; Burgart LJ; Honchel R; Halling KC
Cancer Res; 1996 Nov; 56(21):4836-40. PubMed ID: 8895729
[TBL] [Abstract][Full Text] [Related]
15. Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy.
Samimi G; Fink D; Varki NM; Husain A; Hoskins WJ; Alberts DS; Howell SB
Clin Cancer Res; 2000 Apr; 6(4):1415-21. PubMed ID: 10778972
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation of the hMLH1 gene and protein expression of human mutL homolog 1 and human mutS homolog 2 in resected esophageal squamous cell carcinoma.
Tzao C; Hsu HS; Sun GH; Lai HL; Wang YC; Tung HJ; Yu CP; Cheng YL; Lee SC
J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1371. PubMed ID: 16256791
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of the hMLH1 and hMSH2 proteins in hereditary non-polyposis colon cancer and sporadic colon cancer.
Plevová P; Krepelová A; Papezová M; Sedláková E; Curík R; Foretová L; Navrátilová M; Novotný J; Zapletalová J; Palas J; Nieslanik J; Horácek J; Dvorácková J; Kolár Z
Neoplasma; 2004; 51(4):275-84. PubMed ID: 15254659
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite instability in hereditary and sporadic breast cancers.
Adem C; Soderberg CL; Cunningham JM; Reynolds C; Sebo TJ; Thibodeau SN; Hartmann LC; Jenkins RB
Int J Cancer; 2003 Nov; 107(4):580-2. PubMed ID: 14520695
[TBL] [Abstract][Full Text] [Related]
19. Tissue microarray immunohistochemical expression analysis of mismatch repair (hMLH1 and hMSH2 genes) in endometrial carcinoma and atypical endometrial hyperplasia: relationship with microsatellite instability.
Hardisson D; Moreno-Bueno G; Sánchez L; Sarrió D; Suárez A; Calero F; Palacios J
Mod Pathol; 2003 Nov; 16(11):1148-58. PubMed ID: 14614055
[TBL] [Abstract][Full Text] [Related]
20. Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study.
Stefansson I; Akslen LA; MacDonald N; Ryan A; Das S; Jacobs IJ; Salvesen HB
Clin Cancer Res; 2002 Jan; 8(1):138-43. PubMed ID: 11801550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
